Search Results Search Sort by RelevanceMost Recent Case and Commentary Feb 2005 Quality of Life and Prenatal Decisions, Commentary 1 Ludger Schols, MD Virtual Mentor. 2005;7(2):136-140. doi: 10.1001/virtualmentor.2005.7.2.ccas1-0502. Case and Commentary Feb 2005 Quality of Life and Prenatal Decisions, Commentary 2 Georg Marckmann, MD Virtual Mentor. 2005;7(2):136-140. doi: 10.1001/virtualmentor.2005.7.2.ccas1-0502. History of Medicine Sep 2021 FDA Device Oversight From 1906 to the Present Anna Pisac and Natalia Wilson, MD, MPH A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices. AMA J Ethics. 2021;23(9):E712-720. doi: 10.1001/amajethics.2021.712. Case and Commentary Jan 2005 Confidential Care for Minors and Protecting Genetic Information, Additional Information Faith Lagay, PhD Virtual Mentor. 2005;7(1):53-60. doi: 10.1001/virtualmentor.2005.7.1.ccas10c-0501.
Case and Commentary Feb 2005 Quality of Life and Prenatal Decisions, Commentary 1 Ludger Schols, MD Virtual Mentor. 2005;7(2):136-140. doi: 10.1001/virtualmentor.2005.7.2.ccas1-0502.
Case and Commentary Feb 2005 Quality of Life and Prenatal Decisions, Commentary 2 Georg Marckmann, MD Virtual Mentor. 2005;7(2):136-140. doi: 10.1001/virtualmentor.2005.7.2.ccas1-0502.
History of Medicine Sep 2021 FDA Device Oversight From 1906 to the Present Anna Pisac and Natalia Wilson, MD, MPH A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices. AMA J Ethics. 2021;23(9):E712-720. doi: 10.1001/amajethics.2021.712.
Case and Commentary Jan 2005 Confidential Care for Minors and Protecting Genetic Information, Additional Information Faith Lagay, PhD Virtual Mentor. 2005;7(1):53-60. doi: 10.1001/virtualmentor.2005.7.1.ccas10c-0501.